Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.Bailong Chuangyuan invests 10 million yuan to establish a wholly-owned Kunming subsidiary, a strategic expansion/capex move.

Bailong Chuangyuan announced that, based on its strategic development plan, it will use its own funds of 10 million yuan to establish a wholly-owned subsidiary in Kunming, Bailong Chuangyuan Kunming Biotechnology Co., Ltd., with 100% shareholding. The subsidiary will mainly engage in the sale of food additives, feed additives, health food, and import and export of goods. The company's products include isomaltooligosaccharide, fructooligosaccharide, allulose, and others, which are sold widely in overseas markets. Overseas markets are an important source of revenue for the company. The establishment of the Kunming subsidiary aims to efficiently connect with the Thailand production base by leveraging the China-Laos Railway as a golden corridor, creating a synergistic structure of a Kunming operations hub plus a Thailand production base, reducing cross-border logistics costs, and enhancing customer service capabilities in the Southeast Asian region.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.Bailong Chuangyuan invests 10 million yuan to establish a wholly-owned Kunming subsidiary, a strategic expansion/capex move.